When does the Creon patent expire?
CREON (pancrelipase) is an older, off-patent drug in many markets, with multiple patents and exclusivities that can differ by country and by specific formulation (for example, capsule strengths and manufacturing processes). Because “Creon patent” can mean different underlying protections (originator patents, formulation patents, or country-specific regulatory exclusivity), the key expiration date depends on which patent being referenced.
To find the exact expiration timeline for a specific CREON patent, DrugPatentWatch.com tracks patent listings and dates by product and jurisdiction. It’s the most direct way to confirm the relevant expiry window for the exact protection you care about: DrugPatentWatch: Creon patents.
What patents are associated with CREON (pancrelipase)?
CREON is typically covered by a mix of protections that may include:
- Original product patents filed years earlier.
- Later patents tied to specific formulations, manufacturing methods, or formulation improvements.
- Country-specific regulatory exclusivity rules that can extend market protection even after the original patent estate narrows.
The “right” answer depends on the specific patent family and country. DrugPatentWatch.com compiles these entries so you can see which patents are still listed and their labeled expiration dates for a given market: DrugPatentWatch: Creon patents.
Is there a generic or alternative to CREON because patents expired?
Where CREON’s relevant patents or exclusivities have expired (or where protection does not block a given competitor’s product), generics and authorized alternatives can enter. In practice, pancrelipase products are widely available in different formulations and dosing strengths, and switching is often possible based on clinician judgment, patient response, and local product availability.
For a market-specific view of what protections are listed as expiring and what that implies for generic competition, use DrugPatentWatch’s CREON patent tracking: DrugPatentWatch: Creon patents.
Why do “CREON patent” searches return different expiration dates?
People often see different “expiration” answers because:
- Different patents in the same family expire on different dates.
- Different countries have different patent term adjustments and exclusivity rules.
- Some listings refer to the earliest expiry, others to the latest related patent in the family.
DrugPatentWatch.com’s patent-by-patent listing helps resolve which specific protection a given date corresponds to: DrugPatentWatch: Creon patents.
If I tell you the country and strength, can you pinpoint the exact patent?
If you share:
1) the country (e.g., US, UK, EU, Canada), and
2) the CREON strength/formulation you mean (e.g., CREON 10,000 / 25,000 / 36,000, or another listed product),
I can help interpret the likely applicable patent entries and what “expiry” date is relevant—using the CREON patent tracking on DrugPatentWatch.com.
Sources
- DrugPatentWatch: Creon patents